Skip to content
← Full study record

NCT00567567 · OUTCOME

Intraspinal Extension

Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma · Source last updated 2022-04-28

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
Percentage of patients
Interval / dispersion
Not reported
Time frame
Up to 5 years

What was measured

Percentage of patients with primary tumors with intraspinal extension.

Analysis population: All eligible patients enrolled on ANBL0532.

Groups in this outcome

Single HST (CEM)

Induction therapy + single myeloablative consolidation

Tandem HST (CEM), Randomly Assigned

Induction therapy + tandem myeloablative consolidation

Not Assigned

Patients that either failed during Induction therapy or refused randomization

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Single HST (CEM)206
Tandem HST (CEM), Randomly Assigned176
Not Assigned270

Reported measurements

Source class 1
Values in Percentage of patients · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Single HST (CEM)8.25Not reportedNot reportedNot reportedNot reported
Tandem HST (CEM), Randomly Assigned9.66Not reportedNot reportedNot reportedNot reported
Not Assigned7.78Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        8.25
      2. group Id
        OG001
        value
        9.66
      3. group Id
        OG002
        value
        7.78
denoms
  1. counts
    1. group Id
      OG000
      value
      206
    2. group Id
      OG001
      value
      176
    3. group Id
      OG002
      value
      270
    units
    Participants
description
Percentage of patients with primary tumors with intraspinal extension.
groups
  1. description
    Induction therapy + single myeloablative consolidation
    id
    OG000
    title
    Single HST (CEM)
  2. description
    Induction therapy + tandem myeloablative consolidation
    id
    OG001
    title
    Tandem HST (CEM), Randomly Assigned
  3. description
    Patients that either failed during Induction therapy or refused randomization
    id
    OG002
    title
    Not Assigned
param Type
NUMBER
population Description
All eligible patients enrolled on ANBL0532.
reporting Status
POSTED
time Frame
Up to 5 years
title
Intraspinal Extension
type
SECONDARY
unit Of Measure
Percentage of patients

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice